AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Collegium Pharmaceutical
COLL
Cars.com
CARS
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
GELS Gelteq
- 2.070
- -0.260-11.16%
Close Apr 29 16:00 ET
- 2.000
- -0.070-3.38%
Post 20:01 ET
19.54MMarket Cap-8.63P/E (TTM)
2.290High2.060Low102.01KVolume2.230Open2.330Pre Close220.60KTurnover2.52%Turnover RatioLossP/E (Static)9.44MShares5.50052wk High2.03P/B8.38MFloat Cap0.77052wk Low--Dividend TTM4.05MShs Float5.500Historical High--Div YieldTTM9.87%Amplitude0.770Historical Low2.162Avg Price1Lot Size
About Gelteq Company
Gelteq Ltd. is a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
Company Profile
SymbolGELS
Company NameGelteq
Listing DateOct 29, 2024
Issue Price4.00
Founded2017
CEOMr. Nathan J. Givoni
MarketNASDAQ
Employees20
Fiscal Year Ends06-30
Address100 Albert Road,Level 4
CitySouth Melbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3025
Phone61-3-9087-3990
Websitehttp://www.gelteq.com
Company Executives
- Name
- Position
- Salary
- Nathan J. Givoni
- Director and Chief Executive Officer
- --
- Anthony W. Panther
- Chief Financial Officer and Principal Accounting Officer
- --
- Simon H. Szewach
- Executive Chairman of the Board
- --
- The Honourable Philip A. Dalidakis
- Independent Director
- --
- Professor David Morton
- Independent Director
- --
- Jeffrey W. Olyniec
- Independent Director
- --
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025